Biotech Industry Intelligence

Former Acorda CEO Ron Cohen emerges at Parkinson’s cell therapy biotech Oryon

Former Acorda CEO Ron Cohen emerges at Parkinson’s cell therapy biotech Oryon

Published

2 weeks ago

on

Parkinson’s stem cell therapy developer Oryon Cell Therapies started out Monday morning with three announcements: It enlisted Ron Cohen as its new CEO, netted an additional $21 million in funding and gave an early look …​ ​Read More

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version